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Abstract
Background Data: The clinical management of osteolytic spinal lesion is unique, because
it is challenging to approach these lesions. Surgery and/or radiotherapy has been the
treatments of choice for many years; but, surgery may not be an option for patients
with multiple spinal lesion and poor general medical status, and radiotherapy carries
the risk of vertebral collapse and consequent neural compression. Through different
approaches, vertebroplasty has been introduced into clinical practice as an alternative
to traditional surgery and radiotherapy of osteolytic spinal lesion.
Purpose: To evaluate the safety and efficacy of percutaneous vertebroplasty for selected
patients with osteolytic vertebral compression fractures (VCFs).
Study Design: Retrospective descriptive clinical case study.
Patients and Methods: Between March 2009 and April 2014, fifteen patients with back
pain due to primary or secondary vertebral neoplasm were treated with vertebroplasty.
The patients were followed up for 3-6 months, with an average of 5.4 months. The
clinical effects regarding back pain were evaluated with the visual analog scale (VAS)
preoperatively and at 3 days, one month, 3 months and 6 months post-operatively.
Results: Fifteen patients (9 males and 6 females) were treated by vertebroplasty. The age
ranged from 20 to 60 years with a mean of 44.25 years. All patients presented by severe
disabling back pain. The dorsal spine was affected in nine patients followed by lumbar
spine in five patients and only one case in the cervical spine. The pathology was primary
tumor in nine patients and secondary in six cases. All patients had a satisfying resolution
of their painful symptoms postoperatively. Two cases of cement leakage were reported
without major complication.
Conclusion: Percutaneous Vertebroplasty is an effective technique to treat osteolytic
spinal lesions. It is a valuable, minimally invasive, and efficient method that allows quick
and lasting local resolution of painful symptoms. (2013ESJ058)
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Introduction
The management of osteolytic
metastases involving the spine is unique,
because it is challenging to approach
these lesions. Surgery or radiotherapy
has been the treatments of choice for
several years. However, surgery may not
be an option for patients with multiple
metastases and poor general medical

status, and radiotherapy carries the risk
of vertebral collapse and consequent
neural compression due to delayed
bone reconstruction. Through different
approaches, vertebroplasty has been
introduced into clinical practice as an
alternative to traditional surgical and
radiotherapy treatments of osteolytic
metastases.31
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Osteolytic vertebral fracture is an important cause
of severe back pain, that affect quality of life, physical
and mental health. 3,36 Painful vertebral lesions
are caused by metastatic disease, hemangioma,
myeloma and painful osteoporotic fractures.20,26,40
Percutaneous vertebroplasty (PVP) is a
minimally invasive technique, in which painful
fractured vertebral body is internally splinted
with image guided percutaneous injections of
polymethylmethacrylate (PMMA) cement. The first
percutaneous vertebroplasty was performed in 1984
by the interventional neuroradiologists Galibert and
Deramond for the treatment of a painful aggressive
hemangioma of a vertebral body.10
The spine is the most frequent location for skeletal
metastases, it occurs in up to 40% of patients with
cancer. The most common primary sites are the
breast, prostate and lung, with involvement of 39%,
24 %, and 20 %, respectively and with a slight male
predominance. The thoracic spine is affected in up
to 70% of cases, followed by the lumbar and cervical
areas.14
If the patient satisfies one or more of these
indications, the surgery must be determined by
the tolerability of the patient to the procedure
and, more importantly, by their estimated life
expectancy. Minimally-invasive techniques, namely
PVP, stereotactic radiosurgery and radiofrequency
ablation have challenged the conventional
management of metastatic spinal disease.37,38
These less invasive procedures afford palliation,
have a lower morbidity than conventional surgical
operations and may alter our decision-making in
the future.32 we have addressed PVP in 15 patients
with osteolytic vertebral fracture due to different
pathology.

Patients and Methods
This work includes 15 patients with vertebral
compression fracture secondary to neoplastic lesions
either primary or secondary that were subjected
to percutaneous vertebroplasty in the period from
March 2009 to April 2014. We included in our study
any painful vertebral fracture due to vertebral
tumors either primary (hemangioma, myeloma)
or metastatic lesion. Cases with uncontrolled
coagulopathy, discitis/osteomyelitis or sepsis, spinal
canal and or neural compression vertebral collapse
greater than 70% were excluded from this study.
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Patients were subjected to clinical examinations,
routine laboratory work up and neuroimaging.
Neuroimaging includes Plain x-ray spine, CT spine,
MRI spine and Isotope bone scan. MRI spine is a
must in all patients considered for PVP as it provides
both functional and anatomical information.
Percutaneous vertebroplasty were performed for all
the patients under local anesthesia and sedation in
some cases. The patients were followed up clinically
and radiologically for pain, dose of narcotic and
ambulation.
Patients’ pain levels were assessed according
to the visual analog scale (VAS) score; a score of 0
indicated no pain, and a score of 10 indicated the
most pain imaginable.8
Procedure:
In all cases, a large needle, typically 10 or 11 G,
with a beveled tip, a light orthopedic hammer, and
appropriately radio-opaque cement are required.
PVP may be performed with good quality image
intensification alone or under a combination of
computed tomography and image intensification.
The latter technique is more helpful in cervical and
high thoracic procedures. Patients may be sedated
or under anaesthesia.12,13,25,27
The route by which the needle is inserted varies
depending on the vertebra to be injected. Most
commonly the needle is inserted via a transpedicular
approach. This has the advantage of reducing early
leaks of cement through the entry point into the
bone. Anterolateral (cervical), intercostovertebral
(thoracic) and posterolateral (lumbar) approaches
may also be used. A trans-oral route has been
described for access to the C2 vertebra.9,35
PVP can be performed with injections via both
pedicles (bipedicular), but a single, unipedicular
approach has been the favored technique in this
study. It reduces both trauma to the patient and
the procedure time. The unipedicular technique
requires direction of the needle across the midline
into the anterior third of the vertebral body and
necessitates a more oblique route through the
pedicle. The beveled needle may be steered within
the bone to assist in correct placement.2,22,34
Cement injection should take place under optimal
lighting conditions and with lateral fluoroscopy,
including a control image on a second screen to
allow early identification of cement leakage and
progression of cement towards the posterior

27

vertebral body wall. Typically the operator will have
between 6 and 8 min to mix and inject the cement.
No specific after care is required. The cement sets
within a few minutes of injection. Patients may
safely sit up and walk once they recover from their
sedation or anaesthesia.17,18,33

Results
This study includes 15 patients, nine males and
six females. The age was from 20 to 60 years with a
mean age of 44.25 years. All the patients presented
by severe disabling pain but neurologically intact.
Percutaneous vertebroplasty were performed for
them between March 2009 and April 2014.
The dorsal spine was affected in nine patients
followed by the lumbar spine in five patients and
only one case in the cervical spine. The pathology
was primary tumor in nine patients, seven had
painful hemangioma and two had myeloma. While
six patients had secondary metastatic spread from
pulmonary adenocarcinoma (two cases), thyroid
carcinoma (two cases) and hepatocellular carcinoma
in the last two cases. All the patients had a satisfying

resolution of their painful symptoms postoperatively
according to VAS score. Two cases of cement leakage
were detected without major complication. (Table 1)
Percutaneous vertebroplasty were performed for
all the patients, whom improved markedly as regard
severity of pain, ambulation and reduction of post
operative narcotics. Mean VAS score decreased
from 7.5 ± 0.9 pre-operatively to 2.1 ± 1.8 by 3 days
after the operation. Mean VAS score remained low
throughout the follow-up period, with 1.7 ± 1.6
at one month, 1.6 ± 1.7 at 3 months and 0.9 ± 0.7
at 6 months, respectively. There was a significant
difference between the pre-operative baseline and
each time point of the post-operative follow-up
(P<0.001) (Table 2).
Thirteen cases had no significant complications
and two cases showed cement leak one in the disc
space and one had venous leak but without major
complications. As regard the radiological follow up
of the patients by plain X rays and CT spine, showed
maintained alignment and height of all injected
segments without significant changes. (Figure 1,2)

Table 1. Study’s Patients Epidemiology and Criteria.
Item
Sex
Pathology

Parameters
Male
Female
Primary tumor
Secondary tumor

Site of affection
level affected
Complications

Hemangioma
Myeloma
lung
liver
thyroid

Dorsal spine
Lumbar spine
Cervical spine
One level
Two levels
No complications
Cement leak

No.
9
6
7
2
2
2
2
9
5
1
13
2
13
2

Table 2. Pre- and Post-Operative Follow-Up VAS Scores of Study’s Patients.
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Parameters

Pre-Op

No.
Mean±SD
Versus Pre-Op

15
7.5±0.9

3 days
15
2.1±1.8
P<0.001

Post-Op
1 month
3 months
15
15
1.7±1.6
1.6±1.7
P<0.001
P<0.001

6 months
13
0.9±0.7
P<0.001
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Figure 1. (a) Sagittal T2
MRI of a male patient
20 years old presented
with severe low back
pain due to L2 vertebral
hemangioma. Plain
lateral (b) and AP
(c) radiographs after
right unipedicular
percutaneous
vertebroplasty with
complete cure.

C

B

Discussion
Since the introduction of PVP as a treatment
for haemangiomas of the vertebral body, cement
augmentation is now used for compression fractures
from osteoporosis, multiple myeloma, and metastatic
spinal disease.5 Shimony et al,29 assessed the efficacy
of percutaneous vertebroplasty for metastatic spine
disease. There was an improvement in pain, in 41 of
50 patients while six reported no change and three
had increased pain. The precise mode of action of
PVP is uncertain. The strengthening effect of the
cement injection is thought to provide stability
and prevent further collapse. It is also possible that
the exothermic effects of cement polymerization
directly damage inter-osseous and/or periosteal
nerve endings leading to local death of nerve cells.6,17
Results in patients with metastatic fractures
indicated similar levels of symptom control. One of
the largest series with a total of 289 vertebral body
injections, reported satisfactory outcome (defined
as reduction in analgesic dose) in 78% of patients
with osteoporotic fractures, 83% of patients with
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Figure 2. lateral (a) AP (b)
and T sagittal MRI Image
of a male patient 42
years old presented with
severe axial cervical pain
due to metastasis from
hepatocellular carcinoma.
Images showing PVP of
CV2 through transoral
route with preservation of
its height and alignment.

metastatic lesions and 73% of cases of aggressive
vertebral haemangioma. Pain relief was not related
to the proportion of lesion injected in cases of
metastatic disease or myeloma.4,11
However, Alvarez et al,1 evaluated the efficacy of
vertebroplasty in the treatment of vertebral tumours
in 21 patients with special reference to functional
outcome. Thirteen patients could not walk.
Treatment included percutaneous vertebroplasty
in all patients, radiotherapy in 15 and surgery in
three. Pre-procedural pain, measured by a visual
analogue scale, was 9.1, decreasing to 3.2 after the
procedure and 2.8 by the last follow-up visit. Ten of
13 patients (77%) recovered their walking capacity
and neurological status improved in three of five.
Jang and Lee19 also noted in a series of patients
with osteolytic metastatic spinal tumours, who had
undergone percutaneous vertebroplasty combined
with radiotherapy, that there was relief from pain
in 48% on the third post-operative day, with neither
neurological deterioration nor vertebral collapse
evident at the last follow-up. Nevertheless, they
also noted minor extra vertebral body leakage of
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cement in 72.2% of the levels, all of which were
asymptomatic.
Fourney et al, 7 reported the largest North
American series of augmentation of cement for
metastatic spinal disease. A total of 97 procedures
(65 vertebroplasty and 32 kyphoplasty) were
performed in 56 patients. Patients noted marked
or complete relief from pain after 49 procedures
(84%) and no change after five (9%). Symptomatic
leakage of cement occurred during vertebroplasty
at six of 65 levels (9.2%) while no extravasations
were seen during kyphoplasty. Important findings
included considerable, lasting relief from pain with a
corresponding decrease in the narcotic requirements
in the patients treated.30
Vertebroplasty of C2 can be performed using
anterolateral, posterolateral, translateral, and direct
transoral approaches under fluoroscopic and/or
CT guidance; from a technical point of view, the
procedure is more challenging than those in the
thoracic and lumbar spine because of potential
dangerous complications related to the local unique
anatomical features.15,19,23
We had one case of osteolytic lesion of C2 vertebra
that was injected transoral without significant
complication with any pain postoperatively. The C2
is a part of a complex biomechanical system in the
upper cervical spine. It is surrounded by a number
of delicate neurological and vascular structures, and
it participates in the cranial movement in different
planes: extension, flexion, rotation, lateral bending,
axial loading, and distraction. Thus, having osteolytic
metastases involving C2 is a threatening condition.
Clinical management of the lesions includes open
surgery, radiotherapy, and vertebroplasty. However,
open surgery may not be an option in patients with
multiple metastases and poor general medical
status.31
Radiotherapy is the standard palliative treatment
for metastatic bone tumors, reducing pain in 60–
90% of patients within 10–14 days after the start
of therapy, and maximum benefit is obtained after
12–20 weeks. The late onset of pain alleviation
after the therapy is not acceptable for patients with
unbearable pain. More importantly, radiotherapy
can result in minimal and delayed (2-4 months after
the start of irradiation) bone reconstruction, and
this delay in bone reconstruction increases the risk
of vertebral collapse and consequently of neural
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compression.4
Moreover, additional radiotherapy cannot be
performed again in patients with recurrent pain in
whom radiotherapy has already been performed,
due to the dangers of radiation-induced myelopathy.
Therefore, radiotherapy might not be the best
choice for patients with a poor overall prognosis and
a short expected life span.39
In normal anatomy, many neural and vascular
structures pass through the C2 vertebral body on
their way to supporting functions throughout the
body; C2 is surrounded by the larynx and pharynx
anteriorly, the carotid space laterally, the vertebral
artery and cervical nerve posterolaterally, and the
thecal sac posteriorly. It is crucial to avoid these
structures during interventional procedures.31
The transoral approach is the most straight forward
approach under CT and/or fluoroscopic guidance.
The needle is inserted through the posterior
pharyngeal wall via the open mouth and advanced
through the retropharyngeal space. The approach
is technically feasible; however, there is a potential
risk of infection because maintaining a sterile
field is often difficult with the transoral approach.
Furthermore, nasopharyngeal intubation in patients
with a potentially unstable cervical spine would be
very difficult.16
Sun G et al,31 represent the largest series of patients
with metastasis yet published, demonstrating
the benefit of vertebroplasty for the treatment of
osteolytic metastases at C2 using an anterolateral
approach. They prefer the anterolateral approach
for performing vertebroplasty in C2 because the
procedure carries a low risk of infection and can
be performed under fluoroscopy, which provides
greater real-time guidance than CT does. In
addition, the procedure can be performed under
local anesthesia, avoiding intubation in patients
whose clinical condition is compromised and whose
cervical spines are potentially unstable.
We use prophylactic antibiotics in our case.
The routine use of intravenously administered
prophylactic antibiotics has been reported by
Mathis et al,24 while Kallmes et al,21 reserve use of
these for patients who are substantially immune
compromised. However, complications have been
reported in the anterolateral approach, including
C2 neuralgia due to cement leakage and cerebellar
infarction. Furthermore, the anterolateral approach
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may be not practical in patients with severe pain
who cannot maintain overextension.31
During the injection, the operator watches
carefully for cement leak under continuous
fluoroscopy. Leaks frequently occur through the
vertebral endplates, especially when severe loss
of height has occurred. Lateral leaks are generally
asymptomatic unless posterolateral where they
may involve the exiting nerve root. Anterior leaks
are rare unless the needle has been inserted too
far and penetrated the anterior cortex. Posterior
cement leak is a potentially serious complication if it
involves the spinal canal but should be avoidable by
ensuring satisfactory cement opacification and using
continuous lateral fluoroscopy. Other associated
risks are those related to needle inserted (pedicle
fracture, dural tear) and embolization of cement
to the lungs.28 Complication rates reported in large
series are low. One series reported 6% asymptomatic
epidural leak, 1.6% neuralgic pain related to
epidural leak, 1% asymptomatic cement pulmonary
embolism and 0.5% asymptomatic leak into an
intercostals artery.11,18 The rate of complications
of percutaneous vertebroplasty in patients with
metastatic disease is higher than that in osteoporotic
patients. In patients with tumours, there are likely
to be osteolytic areas with destruction of the bone
cortex, thereby increasing the risk of symptomatic
leakage of polymethylmethacrylate into the spinal
canal and neural foramina.4
Post-procedure deep venous thrombosis and
pneumonia have been reported, as have rib
and pedicle fracture presumably due to trauma
of needle insertion. Individual reports of more
significant complications exist but these should be
rare with correct technique.28,33 The results of all the
evaluated studies show a significant reduction of
pain, a minor complication rate and a fast, easy to
learn and a favorable technique. Vertebroplasty has
gained widespread popularity, mostly because of
significantly high rates of success, low incidence of
complications, brief surgical time, limited sedation,
minimal recovery period, and short or no hospital
stay.

Conclusion
Vertebroplasty is successful, safe, effective,
rapid image guided therapy for painful vertebral
lesions which is suitable for generally unfit

Egy Spine J - Volume 8 - October 2013

patient. It increases mobility, improves quality of
life, decrease narcotic needs and prevent further
vertebral deformity. It is a pain therapy not a cure
for the cause, so the patients continue their specific
treatment of tumor.
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امللخص العربي
احلقن االمسنتى عن طريق اجللد لكسورعظمية منضغطة منهارة بالعمود الفقري .دراسة اولية
خلفية البيانات :إن احلقن االمسنتى عن طريق اجللد لكسورعظمية منضغطة منهارة بالعمود الفقري هي جراحة

فري�دة م�ن نوعه�ا ،ألن�ه ميث�ل حتديً�ا لنه�ج هذه االصاب�ات .وكانت اجلراحة أو العالج اإلش�عاعي العالج املفضل لس�نوات
عدي�دة ولك�ن اجلراح�ة ق�د ال تك�ون خيارا للمرضى الذين يعانون من اصاب�ات متعددة يف العمود الفقري وضعف احلالة
الطبية العامة ،والعالج اإلشعاعي حيمل خطر االنهيار الفقري مع الضغط على االعصاب .لذلك كان استخدام احلقن
االمسنتى كبديل للعالجات اجلراحية والعالج اإلشعاعي التقليدي للكسورالعظمية املنضغطة املنهارة بالعمود الفقري.
تصمي�م الدراس�ة :دراس�ة احلق�ن االمسنت�ى يف  15مريض�ا بكس�ورعظمية منضغط�ة منه�ارة بالعم�ود الفق�ري واآلثار
الس�ريرية س�يتم تقييمها.
اهل�دف :هدف�ت ه�ذه الدراس�ة إىل تقيي�م سلامة وفعالي�ة احلق�ن االمسنت�ى ع�ن طري�ق اجلل�د لبعض املرض�ى املصابني
بكس�ور عظمي�ة منضغط�ة منه�ارة بالعم�ود الفق�ري بس�بب األورام اولي�ة أو ثانوية.
املرض�ى والط�رق :مت علاج  15مريض�ا باحلق�ن االمسنت�ى بين مارس  2009و حتلى ابري�ل  . 2014مت متابعة املرضى ملدة 3
إىل  6أشهر ،مبتوسط  5.4أشهر .مت تقييم اآلثار السريرية مع حجم التناظرية البصرية قبل اجلراحة ،ويف  3أيام ،شهر
و  3أشهر و  6أشهر بعد العملية.
النتائج :مت عالج  15مريضا(تسعة رجال و ست ستات)عن طريق احلقن االمسنتى.تراوحت اعمارهم من  20ال  60سنة
مبتوس�ط س�نى  44س�نة .كان كل املرض�ى يعان�ون م�ن آآلم مربحةبالعم�ود الفق�رى .كان�ت الفق�رات الظهري�ة اكث�ر
تأثرا فى  9حاالت و الفقرات القطنية فى  5حاالت بينما حالة واحدة كانت بالفقرات العنقية .كانت االورام اولية فى
 9ح�االت بينم�ا  6ح�االت ش�هدت اورام ثانوي�ة .كان�ت مجي�ع نتائ�ج املرضى بعد العملية مرضية م�ن األعراض املؤملة .مت
تس�رب األمسن�ت اثن�اء احلقن فى حالتين من دون مضاعفات كبرية.
اخلالص�ة :ان احلق�ن االمسنت�ى ع�ن طري�ق اجلل�د ه�و أس�لوب فع�ال لعلاج الكس�ور العظمية املنه�ارة بالعم�ود الفقري.
وه�ي طريق�ة قيم�ة ،قليل�ة التداخ�ل ،ذات كف�اءة تس�مح حب�ل س�ريع ودائم من األع�راض املؤملة.
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